BR112022026860A2 - Composições e métodos para amplificar polinucleotídeos - Google Patents
Composições e métodos para amplificar polinucleotídeosInfo
- Publication number
- BR112022026860A2 BR112022026860A2 BR112022026860A BR112022026860A BR112022026860A2 BR 112022026860 A2 BR112022026860 A2 BR 112022026860A2 BR 112022026860 A BR112022026860 A BR 112022026860A BR 112022026860 A BR112022026860 A BR 112022026860A BR 112022026860 A2 BR112022026860 A2 BR 112022026860A2
- Authority
- BR
- Brazil
- Prior art keywords
- capture primers
- orthogonal
- amplifiing
- polynucleotides
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 239000000758 substrate Substances 0.000 abstract 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C12Q1/6855—Ligating adaptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/186—Modifications characterised by incorporating a non-extendable or blocking moiety
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/191—Modifications characterised by incorporating an adaptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/204—Modifications characterised by specific length of the oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/107—Temperature of melting, i.e. Tm
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/50—Detection characterised by immobilisation to a surface
- C12Q2565/513—Detection characterised by immobilisation to a surface characterised by the pattern of the arrayed oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/50—Detection characterised by immobilisation to a surface
- C12Q2565/543—Detection characterised by immobilisation to a surface characterised by the use of two or more capture oligonucleotide primers in concert, e.g. bridge amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063077857P | 2020-09-14 | 2020-09-14 | |
| PCT/US2021/048064 WO2022055729A1 (en) | 2020-09-14 | 2021-08-27 | Compositions and methods for amplifying polynucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022026860A2 true BR112022026860A2 (pt) | 2023-04-11 |
Family
ID=78087470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022026860A BR112022026860A2 (pt) | 2020-09-14 | 2021-08-27 | Composições e métodos para amplificar polinucleotídeos |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11913067B2 (enExample) |
| EP (1) | EP4211269B1 (enExample) |
| JP (1) | JP2023540422A (enExample) |
| KR (1) | KR20230069047A (enExample) |
| CN (1) | CN115777024A (enExample) |
| AU (1) | AU2021341688B2 (enExample) |
| BR (1) | BR112022026860A2 (enExample) |
| CA (1) | CA3182296A1 (enExample) |
| ES (1) | ES3007341T3 (enExample) |
| IL (1) | IL299327A (enExample) |
| MX (1) | MX2022014724A (enExample) |
| TW (1) | TW202225412A (enExample) |
| WO (1) | WO2022055729A1 (enExample) |
| ZA (1) | ZA202213367B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022192083A1 (en) * | 2021-03-09 | 2022-09-15 | Illumina, Inc. | Polymers, methods of making polymers, and methods of coupling oligonucleotides to polymers |
| US20250236865A1 (en) * | 2021-10-20 | 2025-07-24 | Illumina, Inc. | Methods for capturing library dna for sequencing |
| US20240052406A1 (en) * | 2022-08-04 | 2024-02-15 | Singular Genomics Systems, Inc. | Competitive methods and compositions for amplifying polynucleotides |
| EP4372101A1 (en) * | 2022-11-02 | 2024-05-22 | EsBiolab LLC | Methods and devices of generating clusters of amplicons |
| WO2024216033A1 (en) * | 2023-04-14 | 2024-10-17 | Illumina, Inc. | Capturing and amplifying polynucleotides |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0514909D0 (en) | 2005-07-20 | 2005-08-24 | Solexa Ltd | Methods of nucleic acid amplification and sequencing |
| PT2669387T (pt) * | 2009-08-25 | 2016-09-20 | Illumina Inc | Métodos para selecção e amplificação de polinucleótidos |
| US9029103B2 (en) * | 2010-08-27 | 2015-05-12 | Illumina Cambridge Limited | Methods for sequencing polynucleotides |
| US8895249B2 (en) | 2012-06-15 | 2014-11-25 | Illumina, Inc. | Kinetic exclusion amplification of nucleic acid libraries |
| EP2840148B1 (en) * | 2013-08-23 | 2019-04-03 | F. Hoffmann-La Roche AG | Methods for nucleic acid amplification |
| GB201410646D0 (en) | 2014-06-14 | 2014-07-30 | Illumina Cambridge Ltd | Methods of increasing sequencing accuracy |
| PT3218511T (pt) * | 2014-11-11 | 2020-07-23 | Illumina Cambridge Ltd | Métodos e dispositivos para produção e sequenciamento de grupos monoclonais de ácido nucleico |
| DK3234187T3 (da) * | 2014-12-15 | 2021-05-25 | Illumina Inc | Fremgangsmåde til enkeltmolekyleanbringelse på et substrat |
| ITUA20162640A1 (it) * | 2016-04-15 | 2017-10-15 | Menarini Silicon Biosystems Spa | Metodo e kit per la generazione di librerie di dna per sequenziamento massivo parallelo |
| WO2018071522A1 (en) * | 2016-10-11 | 2018-04-19 | Life Technologies Corporation | Rapid amplification of nucleic acids |
| GB201704754D0 (en) | 2017-01-05 | 2017-05-10 | Illumina Inc | Kinetic exclusion amplification of nucleic acid libraries |
| AU2019368024B2 (en) * | 2018-10-24 | 2026-02-12 | University Of Washington | Methods and kits for depletion and enrichment of nucleic acid sequences |
| DK3899037T3 (da) * | 2018-12-19 | 2023-11-06 | Illumina Inc | Fremgangsmåder til forbedring af polynukleotidklyngeklonalitetsprioritet |
| WO2021173666A1 (en) * | 2020-02-26 | 2021-09-02 | Illumina, Inc. | Kits for genotyping |
| PL3969618T3 (pl) * | 2020-03-09 | 2024-01-03 | Illumina, Inc. | Sposoby sekwencjonowania polinukleotydów |
-
2021
- 2021-08-27 BR BR112022026860A patent/BR112022026860A2/pt not_active Application Discontinuation
- 2021-08-27 IL IL299327A patent/IL299327A/en unknown
- 2021-08-27 US US17/459,966 patent/US11913067B2/en active Active
- 2021-08-27 EP EP21790611.4A patent/EP4211269B1/en active Active
- 2021-08-27 ES ES21790611T patent/ES3007341T3/es active Active
- 2021-08-27 MX MX2022014724A patent/MX2022014724A/es unknown
- 2021-08-27 WO PCT/US2021/048064 patent/WO2022055729A1/en not_active Ceased
- 2021-08-27 AU AU2021341688A patent/AU2021341688B2/en active Active
- 2021-08-27 CN CN202180046824.0A patent/CN115777024A/zh active Pending
- 2021-08-27 KR KR1020227045843A patent/KR20230069047A/ko active Pending
- 2021-08-27 JP JP2022580750A patent/JP2023540422A/ja active Pending
- 2021-08-27 CA CA3182296A patent/CA3182296A1/en active Pending
- 2021-09-10 TW TW110133695A patent/TW202225412A/zh unknown
-
2022
- 2022-12-09 ZA ZA2022/13367A patent/ZA202213367B/en unknown
-
2024
- 2024-01-22 US US18/419,082 patent/US20240240243A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES3007341T3 (en) | 2025-03-19 |
| AU2021341688B2 (en) | 2025-09-18 |
| MX2022014724A (es) | 2023-03-06 |
| EP4211269A1 (en) | 2023-07-19 |
| US20240240243A1 (en) | 2024-07-18 |
| US20220090187A1 (en) | 2022-03-24 |
| IL299327A (en) | 2023-02-01 |
| TW202225412A (zh) | 2022-07-01 |
| US11913067B2 (en) | 2024-02-27 |
| EP4211269B1 (en) | 2024-11-06 |
| ZA202213367B (en) | 2025-03-26 |
| AU2021341688A1 (en) | 2023-01-05 |
| WO2022055729A1 (en) | 2022-03-17 |
| JP2023540422A (ja) | 2023-09-25 |
| CA3182296A1 (en) | 2022-03-17 |
| KR20230069047A (ko) | 2023-05-18 |
| CN115777024A (zh) | 2023-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022026860A2 (pt) | Composições e métodos para amplificar polinucleotídeos | |
| BR112018012914A2 (pt) | composto, método para tratar, prevenir ou melhorar um ou mais sintomas de câncer, método para tratar, prevenir ou melhorar um ou mais sintomas de uma doença inflamatória e composição farmacêutica | |
| BR112023018619A2 (pt) | Inibidores de heteroaril de calicreína plasmática | |
| CO2022010330A2 (es) | Dosificación de gamma-hidroxibutirato (ghb) | |
| BR112012014190A2 (pt) | composição farmacêutica para o tratamento da síndrome do olho seco | |
| MX2024012801A (es) | Inhibidores de parp1 de azetidina y pirrolidina y usos de estos | |
| MX2018002049A (es) | Diacereina o sus analogos para inhibir la expresion de proteina como mota relacionada a la apoptosis que contiene un dominio de reclutamiento de caspasa (asc), expresion de dominios de pirina y familia nlr que contienen 3 (nlrp3) y/o formacion de complejo de inflamasoma de nlrp3. | |
| CU20220005A7 (es) | Inhibidores tricíclicos de kars dependientes de akr1c3 | |
| BR112018001297A2 (pt) | composição fotocrômica curável e artigo fotocrômico | |
| BR112018009124A2 (pt) | estrutura absorvente | |
| BR112018013820A2 (pt) | análogos de egf(a) com substituintes de ácido graxo | |
| BR112017018187A2 (pt) | composições compreendendo combinações de ácidos orgânicos | |
| BR112017028509A2 (pt) | composições incluindo um politiol, um composto insaturado e um corante, e métodos relacionados a tais composições | |
| BR112022001365A2 (pt) | Formas cristalinas de um inibidor de cd73 | |
| MX2023008004A (es) | Derivado de adenosina y composicion farmaceutica que lo comprende. | |
| EP4181916A4 (en) | Solid delta9-tetrahydrocannabinol (delta9-thc) compositions | |
| BR112023000294A2 (pt) | Composições com atividade virucida e/ou antiviral | |
| MX2018009655A (es) | Compuestos antagonistas receptores de somatostatina y métodos para utilizarlos. | |
| BR112018006029A2 (pt) | óleo aromático de baixo voc e baixo odor | |
| BR112021024257A2 (pt) | Dispositivo para aplicação de composições de emulsão | |
| BR112023022917A2 (pt) | Moduladores de trex1 | |
| BR112017028185A2 (pt) | composições farmacêuticas sólidas para tratar hcv | |
| BR112017008359A2 (pt) | composto, composição, utilização e método para a proteção de uma superfície ou tecido de raios uv | |
| BR112018000982A2 (pt) | composições farmacêuticas sólidas para tratar hcv | |
| BR112023022298A2 (pt) | Moduladores de trex1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |